NCT07633756
- Conditions
- Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +7 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Open Label
Explore clinical trials studying Open Label. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Open Label trial results
Active, not recruiting
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
NCT05929235
- Conditions
- Advanced Urothelial Carcinoma, Open Label, Oral Drug Administration
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
- The University of Chicago Medicine Chicago, Illinois, United States
Active, not recruiting
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants
NCT07413367
- Conditions
- Open Label, Pharmakokinetic, Phase 1
- Locations
-
- Syneos Health Clinique, Inc. Québec, Quebec, Canada
NCT01789528
- Conditions
- CAZ-AVI, CXL, Effect on Intestinal Flora, +3 more
- Locations
-
- Research Site Stockholm, Sweden